Global Point-of-Care Molecular Diagnostics Market Size, Status and Forecast 2019-2025
Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system.
Increased need for accurate and faster testing methods and results for the molecular tests is expected to propel the market growth.
In 2018, the global Point-of-Care Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Laboratories, Bayer Healthcare
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Market segment by Type, the product can be split into
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
Market segment by Application, split into
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Point-of-Care Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Increased need for accurate and faster testing methods and results for the molecular tests is expected to propel the market growth.
In 2018, the global Point-of-Care Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Laboratories, Bayer Healthcare
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Market segment by Type, the product can be split into
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
Market segment by Application, split into
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Point-of-Care Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
